Aristotle University Of Thessaloniki (AUTH)
Φαρμακοκινητική μελέτη της σπαρφλοξασίνης στη χρόνια νεφρική ανεπάρκεια
Abstract
dc:descriptionThe pharmacokinetics of Sparfloxacin, a new third generation quinolone, was studied in 7 healthy volunteers, in 20 patients with different degree of chronic renal failure, in 8 patients undergoing haemodialysis and 6 patients undergoing continuous ambulatory peritoneal dialysis. Sparfloxacin was given in one dose of 400 mg per os. The most important conclusions are summarized as follow. 1. The Mean Serum concentration of Sparfloxacin in healthy volunteers was 1,2 mg/lit and the time of maximum concentration (Tmax) was 2,1 hours. The plasma concentration, 24 hours later was many times greater than the MICS for the sensitive organisms. The serum half life was 16,2 hours which permits the once daily dosage. The main elimination pathway is non renal, through the liver, bileand intestine as we can conclude from the renal clearance. 2. In patients with different degree of chronic renal failure the plasma concentration of sparfloxacin was a little higher than the healthyvolunteers and independent of the severity of chronic renal failure. The serum half-life was double than in the healthy volunteers (33-37 hours). The renal clearance of sparfloxacin was 7,2 ml/min, 5,6ml/min and 3,7 ml/min in the patients with light, medium and severe of chronic renal failure respectively. According to our findings we suggest that in these patients we give 400 mg sparfloxacin the first day and 200 mg every second day. 3. Haemodialysis increases the elimination of sparfloxacin by 30 % of the dosage. 4. During continuous ambulatory peritoneal dialysis the elimination ofsparfloxacin was 1,6 % of the dosage.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2002
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Sofos, Antonios
- Σοφός, Αντώνιος
Subjects
dc:subject × 9Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/14043